This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Kong Kook Pharmaceutical Co., Ltd.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Innovations of Il Ho Lim in Sustained Release Microparticles
Introduction
Il Ho Lim is a notable inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained release microparticles. His innovative approach aims to enhance the therapeutic effects of various drugs through advanced preparation methods.
Latest Patents
Il Ho Lim holds a patent for a "Sustained release microparticle and method for preparing the same." This patent discloses a method for preparing sustained release microparticles that release a physiologically active substance over extended periods. The process involves a multi-emulsion technique where a drug of interest is dissolved or dispersed in at least two oils, creating multiple primary oil phases or emulsions. Each of these emulsions contains a biodegradable polymer. The primary oil phases are then dispersed in an aqueous phase, and organic solvents are removed to produce microparticles. This method allows for the continuous release of drugs, such as luteinizing hormone-releasing hormones, in vivo, thereby improving therapeutic effects.
Career Highlights
Il Ho Lim is associated with Kong Kook Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical innovations. His work focuses on developing advanced drug delivery systems that can significantly impact patient care and treatment outcomes.
Collaborations
Il Ho Lim has collaborated with notable colleagues, including Mork Soon Park and Pyung Keun Myung. These collaborations have contributed to the advancement of research and development in the field of sustained release technologies.
Conclusion
Il Ho Lim's innovative work in sustained release microparticles represents a significant advancement in pharmaceutical technology. His contributions have the potential to enhance drug delivery systems and improve therapeutic outcomes for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile